fbpx An update on Mmr | Page 174 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

EU funding for robotics research

Nowadays, over two-thirds of European workers in manufacturing are employed in small and medium-sized enterprises (SMEs). This is a considerable percentage that UE must consider in its decision concerning funding for Research and Development. One of the most significant aim of SMEs is to offer a valid answer to changing production needs that are developing more and more quickly in our contemporary society, and robotics represents in this sense one of the major challenges.